Our research in Edinburgh
Edinburgh is home to one of our Cancer Research UK Centres, which brings together scientists, doctors and nurses from across the city, harnessing local research expertise to improve the lives of people with cancer.
Scientists at the Edinburgh Centre are focusing on bowel, breast and ovarian cancers, and their work will build on Edinburgh’s world class research into the genetics and biology of cancer. You can find out more on our Centres website.
Our Children's Cancer Trials Team co-ordinates groundbreaking trials in 21 centres across the UK and Ireland, including the Royal Hospital for Sick Children in Edinburgh. These trials bring cutting-edge science from the lab to the bedside, making innovative new treatments available to children with cancer.
Below are some of the highlights of our research in Edinburgh, or you can find out more in our Edinburgh leaflet (pdf download). Visit MyProjects to donate directly to our research in the city.
Click on the names below to find out more about each scientist
These pages contain highlights of the research we fund in this city - we'll be updating and expanding them regularly. Please visit our Funding & Research website for detailed scientific information about our research.
On this page
Bowel cancer
Dr Farhat Din
MRC Human Genetics Unit
University of Edinburgh, Edinburgh
Understanding how aspirin reduces bowel cancer risk
Dr Farhat Din holds a prestigious Cancer Research UK Clinician Scientist Fellowship, investigating how the common household drug aspirin works to reduce the risk of bowel cancer. Her work could help to find the best way to use aspirin to prevent the disease, and lead to better prevention strategies in the future.
Prof Malcolm Dunlop
Department of Surgery, MRC Human Genetics Unit
Western General Hospital, Edinburgh
The genetic causes of bowel cancer
Professor Malcolm Dunlop is leading research into the genetic and environmental causes of bowel cancer at the MRC Human Genetics Unit in Edinburgh. Bowel cancer is the UK's third most common cancer and Scotland itself has one of the highest rates of this disease in the world.
Brain tumours
Dr Sara Erridge
Edinburgh Cancer Centre
University of Edinburgh, Edinburgh
Improving treatment for brain tumours
Dr Sara Erridge is a cancer doctor specialising in the treatment of brain tumours. She is running a clinical trial to find the best way to treat a type of brain tumour called glioma.
Children's cancers
Dr Hamish Wallace
Royal Hospital for Sick Children
University of Edinburgh, Edinburgh
Improving treatment for Hodgkin’s lymphoma
Dr Hamish Wallace is based at the Royal Hospital for Sick Children in Edinburgh, where he is running an international clinical trial to improve treatment for young people with Hodgkin's lymphoma.
Hodgkin's lymphoma
Dr Hamish Wallace
Royal Hospital for Sick Children
University of Edinburgh, Edinburgh
Improving treatment for Hodgkin’s lymphoma
Dr Hamish Wallace is based at the Royal Hospital for Sick Children in Edinburgh, where he is running an international clinical trial to improve treatment for young people with Hodgkin's lymphoma.
Leukaemia
Professor Claus Nerlov
Institute for Stem Cell Research
University of Edinburgh, Edinburgh
Stem cells and faulty genes at the heart of cancer
Professor Claus Nerlov is an expert in stem cells – the ‘immortal’ cells that produce all the different tissues of the body. There is an increasing amount of evidence to show that rogue stem cells may lie at the heart of many different types of cancer, including leukaemia. Professor Nerlov and his team are searching for the faulty genes that drive the growth of leukaemia stem cells, and developing drugs to target them.
No specific cancer type
Prof Margaret Frame
Cell Adhesion Signalling Laboratory
University of Edinburgh, Edinburgh
How do cancer cells spread - and how can we stop them?
Professor Margaret Frame and her team at University of Edinburgh are tackling one of the biggest challenges in cancer treatment - how to stop the disease spreading to other parts of the body. The researchers are investigating how cancer cells break away from a tumour and start moving, to find out how this process could be stopped.
Increase text
Decrease text
Print this page
